COMI SUSANNA

Renda, A., Antoniou, A., Quadri, M., Comi, S., Amenta, A., Sesana, S., et al. (2026). MMP2-Responsive Liposomes Targeting LDLR Enhance the Effectiveness of Anti-Cancer Drugs in Treating Melanoma. ADVANCED THERAPEUTICS, 9(1) [10.1002/adtp.202500257]. Dettaglio

Amenta, A., Comi, S., Kravicz, M., Seneci, P., Pellegrino, S., Re, F. (2025). A novel, glutathione-activated prodrug of pimasertib loaded in liposomes for targeted melanoma therapy [Altro]. Dettaglio

Amenta, A., Comi, S., Kravicz, M., Sesana, S., Antoniou, A., Passarella, D., et al. (2025). A novel, glutathione-activated prodrug of pimasertib loaded in liposomes for targeted cancer therapy. RSC MEDICINAL CHEMISTRY, 16(1), 168-178 [10.1039/d4md00517a]. Dettaglio

Sierri, G., Patrucco, M., Ferrario, D., Renda, A., Comi, S., Ciprandi, M., et al. (2024). Targeting specific brain districts for advanced nanotherapies: A review from the perspective of precision nanomedicine. WILEY INTERDISCIPLINARY REVIEWS. NANOMEDICINE AND NANOBIOTECHNOLOGY, 16(5 (September/October 2024)) [10.1002/wnan.1991]. Dettaglio